These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28542378)

  • 1. Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect.
    Evers C; Fischer C; Dikow N; Schott S
    PLoS One; 2017; 12(5):e0177893. PubMed ID: 28542378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.
    Vetter L; Keller M; Bruckner T; Golatta M; Eismann S; Evers C; Dikow N; Sohn C; Heil J; Schott S
    Breast Cancer Res Treat; 2016 Apr; 156(2):289-99. PubMed ID: 26960712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term experiences with genetic consultation in people with hereditary breast and ovarian cancer.
    Eismann S; Vetter L; Keller M; Bruckner T; Golatta M; Hennings A; Domschke C; Dikow N; Sohn C; Heil J; Schott S
    Arch Gynecol Obstet; 2016 Nov; 294(5):1011-1018. PubMed ID: 27282618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
    Staudigl C; Pfeiler G; Hrauda K; Renz R; Berger A; Lichtenschopf R; Singer CF; Tea MK
    BMC Cancer; 2016 Jul; 16():436. PubMed ID: 27391110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.
    Raphael J; Verma S; Hewitt P; Eisen A
    J Genet Couns; 2016 Dec; 25(6):1309-1316. PubMed ID: 27228984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
    Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
    Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Retrospective Exploration of the Impact of the 'Angelina Jolie Effect' on the Single State-Wide Familial Cancer Program in Perth, Western Australia.
    Freedman R; Mountain H; Karina D; Schofield L
    J Genet Couns; 2017 Feb; 26(1):52-62. PubMed ID: 27265404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.
    Vos J; Oosterwijk JC; Gomez-Garcia E; Menko FH; Collee MJ; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Patient Educ Couns; 2012 Feb; 86(2):239-51. PubMed ID: 21684708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling.
    Albada A; van Dulmen S; Lindhout D; Bensing JM; Ausems MG
    Fam Cancer; 2012 Mar; 11(1):85-95. PubMed ID: 21901499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
    Roshanai AH; Rosenquist R; Lampic C; Nordin K
    Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
    Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.
    Albada A; van Dulmen S; Dijkstra H; Wieffer I; Witkamp A; Ausems MG
    J Genet Couns; 2016 Apr; 25(2):279-89. PubMed ID: 26321750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up effects of a tailored pre-counseling website with question prompt in breast cancer genetic counseling.
    Albada A; van Dulmen S; Spreeuwenberg P; Ausems MG
    Patient Educ Couns; 2015 Jan; 98(1):69-76. PubMed ID: 25455796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
    Brédart A; Kop JL; Dick J; Cano A; De Pauw A; Anota A; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
    BMJ Open; 2019 Sep; 9(9):e029926. PubMed ID: 31551380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
    de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
    Trials; 2014 Mar; 15():86. PubMed ID: 24649895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.